Hybrid eventIn-person & virtual
June 21–23, 2027Rome, Italy

Speaker

Domokos Gero

DGDomokos Gero, Semmelweis University Medical School

Domokos Gero

Semmelweis University Medical School

Hungary

About Domokos Gero

Dr. Domokos Gero graduated as an MD at the Semmelweis University Medical School in 2000 and also received his PhD degree at the Semmelweis University. In 2000, he started transgenic mouse research in Dr. Mozes’ laboratory focusing on gene therapeutic approaches against renal fibrosis at the Pathophysiology Department of Semmelweis University, then from 2006 he has started working on cell-based drug screening projects after he joined the CellScreen Research Center at the University. In 2010, he was invited to lead the cell-based drug screening group in Dr. Csaba Szabo’s lab and became a faculty of the Department of Anesthesiology, University of Texas Medical Branch (UTMB), USA and continued his work there on early drug discovery projects. In 2015 he moved to the UK, receiving a Marie Curie fellowship and joined the University of Exeter Medical School, Devon, UK for 2 years working with Dr. Matt Whiteman on further characterization of mitochondrial hydrogen-sulfide donors. Since 2017, he has been teaching at the Institute of Translational Medicine, Semmelweis University Medical School, Hungary and stated his own cell-based screening laboratory. He has published over 50 research papers.

1 Previous Presentation

Past editions

Join the Chemistry 2027 delegation

Rome · June 21–23, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us